News

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Filler™ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.

Validated University of Calgary research demonstrates broad-spectrum efficacy of core-shell calcium hydroxide-calcium carbonate (CSCC(TM)) particles. Biosenta Inc. announced that two independent, peer-reviewed studies confirmed that its proprietary Tri-Filler™ nanoparticles achieved complete (100%) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional biocides.

A University of Calgary research team, partnered with Biosenta Inc., has developed a method to transform limestone into a long-lasting antimicrobial nanoparticle. This new "shell and core" technology has a durable active ingredient, calcium hydroxide, and has been proven effective against various harmful pathogens. Potential applications include enhancing concrete, paint for healthcare settings, and coatings for food packaging and high-touch surfaces.

Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability.

Biosenta announces significant advancements at its state-of-the-art bench scale production facility.

Biosenta has been making the innovative strides in the realm of antimicrobial biotechnology.

Biosenta announces technological and operational advancements with successful construction and operation of a bench scale production plant.

Biosenta announces a pivotal discovery revealed that Tri-Filler™ effectively sterilizes a wide range of microorganisms.

Biosenta Inc. announces further advances in research and development of Tri-Filler™

Biosenta Inc. announces further advances in research and development of the Tri-Filler™ particle.

Biosenta Inc. has signed an MOU with Voran Group Ventures Ltd. for the commercialization of Biosenta’s Tri-Filler® antimicrobial products.

How to mix the right ingredients for an environmentally friendly disinfectant

University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry

Biosenta announces that it has granted to certain directors, officers, employees and consultants of the Company 350,000 stock options.

Today, Biosenta realized its first purchase order and payment from the supply and purchase agreement with SANITIZATION 360.

Biosenta live on CTV News Ottawa in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta’s stock closed at 0.75 CAD +0.37 (97.37%). This is in step with Biosenta’s strategic business plan grow the company.

Biosenta live on CTV News Toronto in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta live on CTV News Barrie in Ontario Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.

Biosenta live on CTV News Calgary in Alberta Canada, with their new Canada Health approved true™ disinfectant targeting COVID-19.